Alnylam Pharmaceuticals
ALNY
#554
Rank
$42.28 B
Marketcap
$318.85
Share price
-3.01%
Change (1 day)
19.50%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend history for this company